| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Accuracy of the tuberculosis molecular bacterial load assay to diagnose and monitor response to anti-tuberculosis therapy: a longitudinal comparative study with standard-of-care smear microscopy, Xpert MTB/RIF Ultra, and culture in Uganda
|
Musisi, Emmanuel
|
|
|
5 |
4 |
p. e345-e354
|
article
|
| 2 |
Anorectal Neisseria gonorrhoeae infections in women with and without reported anal sex and sex workers in sexual health centres in the Netherlands: a retrospective cohort study
|
Visser, M
|
|
|
5 |
4 |
p. e326-e334
|
article
|
| 3 |
Benchmarking CRISPR-BP34 for point-of-care melioidosis detection in low-income and middle-income countries: a molecular diagnostics study
|
Pakdeerat, Sukripong
|
|
|
5 |
4 |
p. e379-e389
|
article
|
| 4 |
Characteristics of the SARS-CoV-2 omicron HK.3 variant harbouring the FLip substitution
|
Kosugi, Yusuke
|
|
|
5 |
4 |
p. e313
|
article
|
| 5 |
Diagnostic tests for human Schistosoma mansoni and Schistosoma haematobium infection: a systematic review and meta-analysis
|
Vaillant, Michel T
|
|
|
5 |
4 |
p. e366-e378
|
article
|
| 6 |
Dynamics and persistence of antimicrobial resistance genes and gut microbiome after travel
|
Shen, Cong
|
|
|
5 |
4 |
p. e314
|
article
|
| 7 |
Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial
|
Sewunet, Tsegaye
|
|
|
5 |
4 |
p. e355-e365
|
article
|
| 8 |
Emerging threats: global distribution and diversity of carbapenem resistance genes in Kluyvera intermedia
|
Monte, Daniel F M
|
|
|
5 |
4 |
p. e310-e311
|
article
|
| 9 |
GONE to combat onchocerciasis
|
Bagcchi, Sanjeet
|
|
|
5 |
4 |
p. e315
|
article
|
| 10 |
Heteroresistance is a cause of discrepant antibiotic susceptibility testing results
|
Ozturk, Tugba
|
|
|
5 |
4 |
p. e312
|
article
|
| 11 |
Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease
|
O’Donnell, Jake S
|
|
|
5 |
4 |
p. e400-e408
|
article
|
| 12 |
Influenza incidence, lineages, and vaccine effectiveness estimates in Lima, Peru, 2023
|
Acevedo-Rodriguez, Juan Gonzalo
|
|
|
5 |
4 |
p. e308-e309
|
article
|
| 13 |
Non-SARS-CoV-2 respiratory viral detection and whole genome sequencing from COVID-19 rapid antigen test devices: a laboratory evaluation study
|
Moso, Michael A
|
|
|
5 |
4 |
p. e317-e325
|
article
|
| 14 |
Phase 2 trial of a novel tuberculosis drug launched
|
Holt, Ed
|
|
|
5 |
4 |
p. e316
|
article
|
| 15 |
Shoring up the foundations of pathogen surveillance
|
The Lancet Microbe,
|
|
|
5 |
4 |
p. e307
|
article
|
| 16 |
Tracing the origin of SARS-CoV-2 omicron-like spike sequences detected in an urban sewershed: a targeted, longitudinal surveillance study of a cryptic wastewater lineage
|
Shafer, Martin M
|
|
|
5 |
4 |
p. e335-e344
|
article
|
| 17 |
Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study
|
Maldonado, Natalia
|
|
|
5 |
4 |
p. e390-e399
|
article
|
Journal description